Axis-Shield Liquid Stable (LS) 2-Part HOMOCYSTEINE REAGENT; 100 test format, 1000 test format, an...

FDA Device Recall #Z-1946-2015 — Class II — March 20, 2015

Recall Summary

Recall Number Z-1946-2015
Classification Class II — Moderate risk
Date Initiated March 20, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Axis-Shield Diagnostics, Ltd.
Location Dundee
Product Type Devices
Quantity 52 kits + 75 kits Beckman Coulter Brand OUS

Product Description

Axis-Shield Liquid Stable (LS) 2-Part HOMOCYSTEINE REAGENT; 100 test format, 1000 test format, and 200 test format; and Private Label: (Distributed by BECKMAN COULTER, for professional use only, on the BECKMAN COULTER AU platforms (AU400, AU480, AU680 and AU5800)) Product Usage: For in-vitro quantitative determination of total homocysteine in human plasma or serum.

Reason for Recall

Deterioration in performance of the Liquid Stable (LS) 2-Part HOMOCYSTEINE REAGENT resulting in under recovery.

Distribution Pattern

Worldwide Distribution - US Nationwide in the states of: KY, WA, CA, and PA and the country of Germany.

Lot / Code Information

Part Number/Lot Number: FHBC100/802899574; FHRWR100/802899249; FHRWR1000/802899248; FHRWR200/802899989; FHRWR200/802899250; FHRWCN1/802900104

Other Recalls from Axis-Shield Diagnostics, Ltd.

Recall # Classification Product Date
Z-0744-2020 Class II Axis-Shield Liquid Stable (LS) 2-Part HOMOCYSTE... Sep 16, 2019
Z-0743-2020 Class II Axis-Shield Liquid Stable (LS) 2-Part HOMOCYSTE... Sep 16, 2019
Z-0742-2020 Class II Axis-Shield Liquid Stable (LS) 2-Part HOMOCYSTE... Sep 16, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.